Abstract:Viral infection triggers the activation of transcription factor IRF3, and its activity is precisely regulated for robust antiviral immune response and effective pathogen clearance. However, how full activation of IRF3 is achieved has not been well defined. Herein, we identified BLK as a key kinase that positively modulates IRF3-dependent signaling cascades and executes a pre-eminent antiviral effect. BLK deficiency attenuates RNA or DNA virus-induced ISRE activation, interferon production and the cellular antiviral response in human and murine cells, whereas overexpression of BLK has the opposite effects. BLK-deficient mice exhibit lower serum cytokine levels and higher lethality after VSV infection. Moreover, BLK deficiency impairs the secretion of downstream antiviral cytokines and promotes Senecavirus A (SVA) proliferation, thereby supporting SVA-induced oncolysis in an in vivo xenograft tumor model. Mechanistically, viral infection triggers BLK autophosphorylation at tyrosine 309. Subsequently, activated BLK directly binds and phosphorylates IRF3 at tyrosine 107, which further promotes TBK1-induced IRF3 S386 and S396 phosphorylation, facilitating sufficient IRF3 activation and downstream antiviral response. Collectively, our findings suggest that targeting BLK enhances viral clearance via specifically regulating IRF3 phosphorylation by a previously undefined mechanism. Transcription factor IRF3-mediated type I interferon production is essential for antiviral innate immunity. Understanding how full activation of IRF3 is regulated is important to decipher the detailed mechanisms of IRF3-dependent signal transduction. Here, we report that BLK promotes IRF3 activation, leading to elevated antiviral cytokine production against multiple invading viruses both in vivo and in vitro . Upon viral infection, BLK undergoes Y309 autophosphorylation and directly phosphorylates IRF3 at Y107, together with TBK1-induced IRF3 S386 and S396 phosphorylation, to achieve sufficient IRF3 activation and elicit robust downstream antiviral responses. Overall, these data suggest that BLK is a critical effector of IRF3 phosphorylation. This study advances the understanding of the precise regulatory mechanisms of IRF3 activation. Manipulation of these mechanisms may help to develop novel therapeutics for infectious and inflammatory diseases.

Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program

Lck/Hck/Fgr-Mediated Tyrosine Phosphorylation Negatively Regulates TBK1 to Restrain Innate Antiviral Responses.

FoxO1 Negatively Regulates Cellular Antiviral Response by Promoting Degradation of IRF3

Phosphatase Pp4 Negatively Regulates Type I Ifn Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating Tbk1

Cytokine Receptor-Like Factor 3 Negatively Regulates Antiviral Immunity by Promoting the Degradation of TBK1 in Teleost Fish

Tyrosine phosphorylation of IRF3 by BLK facilitates its sufficient activation and innate antiviral response

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.

Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling.

Riok3 inhibits the antiviral immune response by facilitating TRIM40-mediated RIG-I and MDA5 degradation

REGγ Regulates Antiviral Response by Activating TBK1-IFNβ Signaling Through Degradation of PPP2CB

Regulation Of I Kappa B Kinase-Related Kinases And Antiviral Responses By Tumor Suppressor Cyld

Type I interferon/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner

Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression

Negative regulation of TBK1-mediated antiviral immunity.

IRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation

Zinc-finger CCHC-type containing protein 8 promotes RNA virus replication by suppressing the type-I interferon responses

RKIP and TBK1 Form a Positive Feedback Loop to Promote Type I Interferon Production in Innate Immunity

HSCARG Negatively Regulates the Cellular Antiviral RIG-I Like Receptor Signaling Pathway by Inhibiting TRAF3 Ubiquitination via Recruiting OTUB1

Casein Kinase II Controls TBK1/IRF3 Activation in IFN Response Against Viral Infection